UNITED STATES OF AMERICA v. AMERISOURCEBERGEN CORPORATION et al

  1. November 07, 2023

    AmerisourceBergen Trims But Can't Beat Feds' Opioid Suit

    A Pennsylvania federal judge on Monday held that AmerisourceBergen must face the bulk of the federal government's suit targeting its role in the opioid epidemic, but allowed the distribution company to avoid civil penalties for any Controlled Substances Act violations occurring before October 2018.

  2. July 31, 2023

    DEA 'Set A Trap' For Opioid Sellers, AmerisourceBergen Says

    AmerisourceBergen says federal drug law enforcers "unfairly set a trap" for the distributor, the latest salvo against the government in a suit over the opioid epidemic.

  3. June 29, 2023

    DOJ Fights AmerisourceBergen's Dismissal Bid In Opioid Suit

    The federal government has urged a Pennsylvania federal court to deny AmerisourceBergen's bid to toss an enforcement action against the drug distribution company in connection with the opioid epidemic, saying the company chose profits over federal drug reporting requirements.

  4. May 02, 2023

    Reject 'Carte Blanche' For Risky Opioid Sales, 4th Circ. Urged

    A West Virginia city and county have told the Fourth Circuit that distributors of addictive painkillers misinterpreted state nuisance law and the federal Controlled Substances Act when seeking to uphold a lower court's dismissal of the local governments' multibillion-dollar opioid lawsuit.

  5. March 31, 2023

    AmerisourceBergen Seeks Toss Of DOJ's Opioid Suit

    Drug distribution giant AmerisourceBergen has asked a Pennsylvania federal court to toss one of the U.S. Department of Justice's most noteworthy enforcement actions in connection with the opioid epidemic, calling the case "overreach."

  6. March 24, 2023

    Opioid Theory Reaches 'Alcohol, Guns, Phones,' 4th Circ. Told

    A West Virginia federal judge's monumental rejection of a multibillion-dollar opioid case correctly avoided a "dramatic rewriting" of state law that would threaten legal exposure for sellers of liquor, cellphones, firearms and other lawful products, drug distributors told the Fourth Circuit on Friday.

  7. January 03, 2023

    Health & Pharma Legal Clashes Didn't Take A Holiday Break

    While many Americans were bringing glad tidings and popping bubbly, attorneys spent the final week of 2022 bringing lawsuits, appeals and other court filings of eye-popping significance for health care providers and drug companies in cases involving the False Claims Act, the opioid crisis and purported price-fixing schemes.